The influences of serum IgE-specific suppressor factor (IgE-TsF) , interleukin-2 (IL-2) , and interleukin-2 receptor (IL-2R) by hyposensitization to children with bronchial asthma
Liu, W.J.; Chiang, C.H.; Huang, T.Y.
Gaoxiong Yi Xue Ke Xue Za Zhi 4(6): 364-371
1988
ISSN/ISBN: 0257-5655 PMID: 3136250 Document Number: 323844
Document emailed within 1 workday
Related Documents
Kanakura, Y.; Sugahara, H.; Mitsui, H.; Ikeda, H.; Furitsu, T.; Yagura, H.; Kitayama, H.; Kanayama, Y.; Matsuzawa, Y. 1993: Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor Cancer Research 53(3): 675-680Mdinaradze, M.D.; Mikheeva, G.A. 1971: State of several indices of nonspecific immunity in children with bronchial asthma under specific hyposensitization therapy Pediatriia 50(6): 27-31
Sims, J.E.; Smith, D.E. 2003: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type Ii and interleukin-1 receptor accessory protein European Cytokine Network 14(2): 77-81
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192
Ninomiya, Y.; Obara, A.; Sugawara, K.; Konishi, K. 1991: A study on interleukin 2 and soluble interleukin 2 receptor in serum and bronchoalveolar lavage fluid from patients with farmer's lung Nihon Kyobu Shikkan Gakkai Zasshi 29(11): 1399-1406
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Réglier-Poupet, H.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood European Cytokine Network 9(4): 633-638
Inanir, A.; Ozoran, K.; Tutkak, H.; Mermerci, B. 2004: The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis Journal of International Medical Research 32(6): 570-582
Qiu, H.B.; Chen, D.C.; Pan, J.Q.; Liu, D.W.; Ma, S. 1999: Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages Zhongguo Yao Li Xue Bao 20(3): 271-275
Qi, T.; Xie, L.; Wang, Y.; Wang, J.; Chen, H.; Zhou, L. 2002: Dynamic variation of serum and stool level of interleukin-2, interleukin-6 and interferon-alpha in children with rotavirus enteritis and its relation to clinical manifestations Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(3): 270-273
Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670
Lucherini, O.M.; Vitale, A.; Obici, L.; Sota, J.; Frediani, B.; Merlini, G.; Rigante, D.; Cantarini, L. 2019: Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) Clinical and Experimental Rheumatology 37 Suppl 121(6): 159-160
Nishi, K.; Nishi, O.; Omoto, Y. 1992: The synthesis of cytokines by human lens epithelial cells--interleukin 1 (IL-1), tumor necrosis factor (TNF) interleukin 6 (IL-6), and epidermal growth factor (EGF) Nippon Ganka Gakkai Zasshi 96(6): 715-720
Ishii, E.; Ohga, S.; Ueda, K.; Akazawa, K. 1991: Serum interleukin-1 and tumor necrosis factor activities in febrile children with acute leukemia International Journal of Hematology 54(1): 79-84
Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Airoldi, I.; Guglielmino, R.; Carra, G.; Corcione, A.; Gerosa, F.; Taborelli, G.; Trinchieri, G.; Pistoia, V. 2002: The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes Haematologica 87(4): 434-442
Arman, A.; Yilmaz, B.; Coker, A.; Inanc, N.; Direskeneli, H. 2006: Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis Clinical and Experimental Rheumatology 24(6): 643-648
Shinkura, H.; Imazeki, I.; Yamazaki, M.; Oda, Y.; Kotoh, M.; Mihara, M. 1998: In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates Anticancer Research 18(2a): 1217-1221
Sun, R.X.; Gennaro, C.; Rocco, S.; Gu, Z.J.; Klein, B. 1997: Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity European Cytokine Network 8(1): 51-56